Global Clinical Innovation
get in touch

We are GCI

We are going to accelerate the journey of life-changing therapies from concept to market while upholding the highest standards of patient safety, data integrity, and regulatory compliance.
  • Company overview

Bringing medical inovations to life

Global Clinical Innovation (GCI) is an Australian-based Clinical Research Organization (CRO) specializing in clinical neuroscience and advanced medical technologies. We partner with biopharmaceutical companies, medical device innovators, and research institutions across national and international markets to deliver high-quality, compliant, and efficient clinical development solutions.

With deep expertise in neuroscience, novel therapeutics, and imaging technologies, GCI expedites the development, validation, and market delivery of groundbreaking healthcare innovations. Our team of seasoned professionals combines scientific excellence, regulatory expertise, and operational precision to provide tailored, end-to-end research services that meet the unique needs of every sponsor.
  • years experience
    working
0 +
  • qualified staff
0 +
  • awards won
0 +
  • projects
    completed
0 +
  • Explore company

Business partner you can trust

01.

Our Vision

To become the most trusted and innovative clinical research partner in the Asia-Pacific region, delivering solutions that improve patient outcomes and transform healthcare globally.
02.

What We Do

To empower sponsors with agile, science-driven, and technology-enabled clinical research solutions that accelerate development timelines, ensure compliance, and create measurable value across the clinical lifecycle.
03.

Core Values

We value transparency, innovation, and quality—putting patients first and collaborating with stakeholders to deliver efficient, impactful clinical research throughout the development lifecycle.
  • Founder Of GCI

A Leader in Stroke Research and Innovation

“We are committed to providing supportive and positive work”
Prof. Mark Parsons
Professor Parsons also holds prestigious academic appointments worldwide and is a pioneer in imaging-guided stroke care. His translational research, entrepreneurial leadership, and digital innovation projects have significantly improved stroke systems and rural healthcare access globally.
Global Recognition in Research & Mentorship

Professor Parsons holds an H-index of 101 with over 23,000 citations and 500+ peer-reviewed publications in top journals like NEJM and Lancet Neurology. He has delivered 200+ invited lectures, chaired 50+ global conferences, and mentored 19 PhD students and 12 postdoctoral researchers—many now leading research worldwide.

Pioneering Clinical Trials in Stroke Care

His groundbreaking leadership in trials such as EXTEND-IA, TASTE, ENCHANTED, and ETERNAL has reshaped international stroke guidelines, including the adoption of tenecteplase and thrombectomy. Phase III NHMRC-funded trials like TASTE and ETERNAL spanned 50+ centres globally.

Global Partnerships & Visionary Leadership

Founder of GCI, Professor Parsons unites science, technology, and industry to accelerate stroke therapies. He works closely with the Shequal Foundation, co chaired the 2023 women in AI & medicine workshop in Kathmandu. Helped establish STEM scholarship to promote women and AI hackathon at LPU India.

Chief Executive Officer

As the Chief Executive Officer of GCI, Dr Longting Lin is driven by a commitment to accelerating the development of life-changing therapies. With a career spanning over 15 years in the life sciences field, she provides the strategic vision and leadership that ensures GCI delivers unparalleled quality, innovation, and partnership to our clients worldwide.
Under Dr Longting Lin’s guidance, GCI has cultivated a culture of collaboration, scientific rigor, and transparency. She is a passionate advocate for integrating digital health technologies to make clinical trials more accessible for patients. Outside of work, Dr Longting Lin is dedicated to mentoring young scientists and supporting local patient advocacy groups. She holds a PhD from University of Newcastle, Australia and serves on the board of the International Stroke Perfusion Imaging Registry
Dr Longting Lin welcomes the opportunity to connect.
Reach out at longting.lin@globalclinicalinnovation.com.au
  • Dr Longting Lin

testimonials

  • Hear from customer
“Your staff is very courteous and quick to respond to any service call we might have. Highly recommended.”
Jane Cooper Google Co-Founder
"Their fresh perspective and innovative strategies have given our business a much-needed revamp."
Anna Perry Director of Recon
"They've not only met our expectations but exceeded them in every project. We give a big thumbs up!"
Andrew Doe CEO of Rondu
  • Our achievements

Awards & recognition

Elevated to Scientia Professor at UNSW

distinction reserved for the top 1% of academics

2024
Darak Award

for Indigenous leadership in stroke research

2023
UNSW Distinguished Research Prize
2021
Lady Mary Fairfax Distinguished Researcher Award
2022
Fellowship, Australian Academy of Health and Medical Scientists
2019
Chinese Stroke Association International Contribution Award
2020
University of Newcastle Alumni Medal
2012
ANZAN Leonard Cox Award for Neuroscience Research
2008
ANZAN Leonard Cox Award for Neuroscience Research
2008
Multiple NHMRC, HMRI, and NSW Health Research Excellence Awards
  • Connect with us

We are committed to delivering only the best

Global Clinical Innovation